BioCurex, Inc.(fka BOCX)

[oraclewizard77]

I think its up to Abbott since applying for FDA approval is a long and expensive process.

The good news as I see it was the joint presentation with Abbott. More good news will be any other payments by Abbott or another license with a different vendor.

They may also want to talk to the FDA on what test data that they need to collect to get FDA approval and work on a large enough test sample to make the procedure worth it.

Obviously like any drug that gets FDA approval and therefore increases the stock price, news of final FDA approval could get us above the $ 10/sh range, but it still looks like a few years off from here.